chartexchange

RGBPP
REGEN BIOPHARMA PFD A
stockOTCPreferred Stock

EODNov 18, 2026
0.00054USD+8.000%(+0.00004)1,959,852
Loading…
Loading…
Healthcare
Biotechnology
HQ
La Mesa, CA, USA
Previous Close
$0.00
Beta
-2.13
52-Week High
$0.13 2025-11-20
52-Week Low
$0.00 2026-11-17
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
2.29M
Avg. Vol 30D
1.19M
Avg. Vol 90D
604,806
Relative Vol
1.65
141.80M
26,512
Jul 5, 2024 · 3-for-1
RGBPP Profile

regen biopharma, inc. focuses on the development of small molecule therapies for treating cancer and autoimmune disorders in the united states. the company intends to develop small molecule nr2f6 that activates to immune cell for oncology and autoimmune diseases. the company was founded in 2012 and is based in la mesa, california. regen biopharma, inc. is a subsidiary of bio-matrix scientific group, inc.

RGBPP Performance
PeriodPriceDateChangeBeta
1W0.002026-11-12-55.00%4.414
1M0.002026-10-20-68.23%-0.044
3M0.002026-08-19-82.58%-1.738
6M0.012026-05-19-89.20%-0.409
1Y0.092025-11-19-99.36%-2.129
2Y0.152024-11-19-99.64%—
5Y32.752021-11-19-100.00%0.203
RGBPP Stock Summary

REGEN BIOPHARMA PFD A (OTC:RGBPP) stock price today is $0.00, and today's volume is 1,959,852. RGBPP is up 8.000% today. The 30 day average volume is 1.19M. RGBPP market cap is $5,467 with 10.12M shares outstanding.